K945550

Substantially Equivalent

ABUSIGN(TM) THC, DOA-THC, ACCUSIGN(TM) THC, DOA-THC, DIOSIGN(TM) THC, DOA-THC

Applicant: Princeton BioMeditech Corp.
Product code: LDJ
Advisory panel: Clinical Toxicology
Date received: 1994-11-14
Decision date: 1995-02-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Princeton, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.